Stoke Therapeutics, Inc. (STOK) insider trading.
In Q3 2026, insiders at Stoke Therapeutics, Inc. reported 15 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 12 sales worth $1.3M.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 12
- Net shares, P minus S
- -40,144
- Insiders
- 3
- Last filed
- 2026-09-03
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Ticho Barry | Officer · CHIEF MEDICAL OFFICER | 9 | 0 | 8 |
| Kaye Edward M. MD | Director | 3 | 0 | 2 |
| Allan Jonathan | Officer · GENERAL COUNSEL & CORP SEC | 3 | 0 | 2 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Ticho Barry | S (D) | 1,600 | $31.06 | 20,110 | Form 4 |
| 2026-09-01 | Ticho Barry | S (D) | 3,945 | $30.51 | 21,710 | Form 4 |
| 2026-08-18 | Kaye Edward M. MD | S (D) | 637 | $32.47 | 124,557 | Form 4 |
| 2026-08-18 | Kaye Edward M. MD | S (D) | 11,930 | $32.01 | 125,194 | Form 4 |
| 2026-08-18 | Ticho Barry | S (D) | 242 | $32.47 | 25,655 | Form 4 |
| 2026-08-18 | Ticho Barry | S (D) | 4,525 | $32.01 | 25,897 | Form 4 |
| 2026-08-18 | Allan Jonathan | S (D) | 145 | $32.47 | 21,225 | Form 4 |
| 2026-08-18 | Allan Jonathan | S (D) | 2,716 | $32.01 | 21,370 | Form 4 |
| 2026-08-14 | Kaye Edward M. MD | M (A) | 26,250 | $0 | 137,124 | Form 4 |
| 2026-08-14 | Ticho Barry | M (A) | 10,000 | $0 | 30,422 | Form 4 |
| 2026-08-14 | Allan Jonathan | M (A) | 6,000 | $0 | 24,086 | Form 4 |
| 2026-08-03 | Ticho Barry | S (D) | 5,907 | $28.95 | 21,691 | Form 4 |
| 2026-08-03 | Ticho Barry | S (D) | 1,269 | $29.45 | 20,422 | Form 4 |
| 2026-07-01 | Ticho Barry | S (D) | 500 | $33.27 | 27,598 | Form 4 |
| 2026-07-01 | Ticho Barry | S (D) | 6,728 | $32.62 | 28,098 | Form 4 |
Transaction codes in this quarter
Get STOK insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1623526&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · STOK company page · Stoke Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Stoke Therapeutics, Inc. (STOK)?
In Q3 2026, insiders at Stoke Therapeutics, Inc. reported 15 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 12 sales worth $1.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Stoke Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/stok.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.